ONLINE TRAININGS FOR GENERAL PRACTITIONERS TREATMENT OPTIONS ON COVID-19 - a collaboration between - RKI
←
→
Page content transcription
If your browser does not render page correctly, please read the page content below
Webseminar schedule • 10.00 – 11.30 am • Organisational information • presentation: Initial respiratory assessment and care Department of Infectious Diseases, Charité Dr. Alexander Uhrig Dr. Miriam Stegemann • Q&A/ discussion 2
Use of the chat • For question/ technological issues • 1. Send questions regarding the content of the presentation • 2. Raise a hand when you want to ask a question/participate in discussion 2. 1. 3
Evaluation of the web seminar • For quality assurance of the training series • Link is shared at the end of the meeting Juni 2021 Infektiologie-Beratungs-Netzwerk 4
Onlinetrainings for GPs: treatment options on COVID-19 Initial respiratory assessment and care 05.08. Department of Infectious Diseases, Charité Dr. Alexander Uhrig Dr. Miriam Stegemann First procedures in case of respiratory deterioration: 10.08. Non-invasive ventilatory support Department of Anesthesiology and Intensive Care Medicine, Charité Dr. Nicolai Andrees Dr. Julius J. Grunow Basic treatment and cure under non-ICU conditions 12.08. Department of Infectious diseases, Charité Dr. Alexander Uhrig Dr. Miriam Stegemann Stabilization of a critical patient for referral with ambulance 17.08. Department of Anesthesiology and Intensive Care Medicine, Charité Dr. Nicolai Andrees Dr. Julius J. Grunow 5 05.08.2021
Learning Objectives • Epidemiology – Spectrum of disease- Course of illness • Screening – Triage – Risk Stratification • Recognition of hypoxemic respiratory failure • Understand how COVID-19 is transmitted • How to stay safe from an airborne pathogen (IPC) • COVID-19 diagnostics 05.08.2021 Initial respiratory assessment and care - Dr. Uhrig, Dr. Stegemann 7
Background – Epidemiology Situation by WHO Region New COVID-19 cases reported by day in Africa by African Union region 05.08.2021 Initial respiratory assessment and care - Dr. Uhrig, Dr. Stegemann 8
Background – Spectrum of disease manifestation 05.08.2021 Initial respiratory assessment and care - Dr. Uhrig, Dr. Stegemann 9
Background – Course of illness COVID-19 Characteristics, Diagnosis, and Management of Covid-19 According to Disease Stage or Severity. RT Gandhi et al. N Engl J Med 2020;383:1757-1766. 05.08.2021 Initial respiratory assessment and care - Dr. Uhrig, Dr. Stegemann 10
SUSPECT CASE - Case definition SUSPECT CASE A patient with any acute respiratory illness: Fever AND at least one sign/symptom of respiratory disease (cough, shortness of breath etc.) Epidemiological information: • Having been in contact with a confirmed or probable COVID-19 case • history of travel to or residence in a location reporting confirmed cases ➠ can only increase the index of suspicion ➠ does not exclude the possibility of COVID-19 Rwanda COVID-19 CLINICAL MANAGEMENT GUIDELINES, 3rd Edition Sept 2020 05.08.2021 Initial respiratory assessment and care - Dr. Uhrig, Dr. Stegemann 11
PROBABLE and CONFIRMED CASE - Case definition PROBABLE CASE (or presumptive positive as per lab result terminology): A suspect case for whom testing for the COVID-19 virus is presumptive. („presumptive“ being the result of the test reported by the laboratory using Antigen Test or PCR method) OR A suspect case for whom testing could not be performed for any reason. CONFIRMED CASE • laboratory confirmation of COVID-19 infection using a PCR method • irrespective of clinical signs and symptoms Rwanda COVID-19 CLINICAL MANAGEMENT GUIDELINES, 3rd Edition Sept 2020 05.08.2021 Initial respiratory assessment and care - Dr. Uhrig, Dr. Stegemann 12
Why Identification and Triage matter 05.08.2021 Initial respiratory assessment and care - Dr. Uhrig, Dr. Stegemann 13
Lowering In-Hospital Transmission of COVID-19 05.08.2021 Initial respiratory assessment and care - Dr. Uhrig, Dr. Stegemann 14
Screening for COVID-19 Case Definition: any acute respiratory illness fever and at least one sign/symptom of respiratory disease: cough, shortness of breath etc. All patients should be screened for COVID-19 using case definition at the first point they access the health system Screening: ▶ Isolating patients who are potentiallypositive cases of COVID-19 ▶ Reducing the spread of the virus within facilities Modified from: WHO Interim Guidance 19 March 2020 COVID-19 Clinical Management Guidelines Rwanda MoH/RBC 05.08.2021 Initial respiratory assessment and care - Dr. Uhrig, Dr. Stegemann 15
Isolation 05.08.2021 Initial respiratory assessment and care - Dr. Uhrig, Dr. Stegemann 16
Triage Triage: ▶ systematically sorting patients by the severity of their clinical syndrome ▶ matching patients with health care resources ▶ regardless of disease state (COVID-19 positive/negative) Modified from: WHO Interim Guidance 19 March 2020 COVID-19 Clinical Management Guidelines Rwanda MoH/RBC 05.08.2021 Initial respiratory assessment and care - Dr. Uhrig, Dr. Stegemann 17
Triage: Severity of Illness Scoring qSOFA CURB65 Criteria Criteria Abnormal mental status Confusion RR ≥ 22 BUN > 19 mg/dl SBP ≤ 100 RR ≥ 30 SBP < 90 /DBP ≤60 [mmHg] Age ≥ 65 years Interpretation Interpretation > 1: mortality ≥ 10% 0: 0.6% mortality 1: 2.7% mortality 2: 6.8% mortality 3: 14% mortality 4-5: 28% mortality Rapid Emergency Medicine Score (REMS) Fan G Eur Respir J 2020;56:2002113 Hu H Acad Emerg Med 2020;27:461-468 05.08.2021 Initial respiratory assessment and care - Dr. Uhrig, Dr. Stegemann 18
Triage : Risk Stratification • Older age (≥ 64 years) • Male sex • Development of ARDS/need for mechanical ventilation • Severity of organ dysfunction on admission • Markers of inflammation/coagulation • Select laboratory studies: Lymphopenia, Neutrophilia, Troponin↑ • Comorbidities: The ACCCOS Investigators Lancet 2021; 397: 1885–94 05.08.2021 Initial respiratory assessment and care - Dr. Uhrig, Dr. Stegemann 19
Triage: Severity of Illness Matching patients with healthcare resources: • Treatment • Treatment location } depend on severity of illness and risk stratification WHO Therapeutics and COVID-19 Living Guideline 20 November 2020 05.08.2021 Initial respiratory assessment and care - Dr. Uhrig, Dr. Stegemann 20
Minimum-Better-Best Monitoring of Respiratory Failure Minimum: Observation of cyanosis, work of breathing, retractions measuring the respiratory rate Better: Pulse oximetry and end-tidal capnography Best: Point-of-care blood gas analysis Trends are more important than single values in assessing wether a patient is at risk for decompensation • Thorough physical examination is critical in evaluating a patient suspected of having respiratory distress • Use a stepwise “look, listen and feel” approach (inspection, auscultation, palpation) • “appearance of the patient”: hypoxemic respiratory failure normally manifests as anxiety/combativeness hypercapnic respiratory failure normally presents with somnolence 05.08.2021 Initial respiratory assessment and care - Dr. Uhrig, Dr. Stegemann 21
Treatment location • Home care • Treatment Facility • Hospital • Community-based • Hospital with: care with: - mechanical ventilation - oxygen therapy - vasopressor therapy - HFNC oxygen (?) - renal replacement (?) - steroid therapy - DTV prophylaxis - antiviral therapeutics (?) Prepare a pathway through the healthcare system for • Patients with different severity of illness • Patients with worsening severity of illness 05.08.2021 Initial respiratory assessment and care - Dr. Uhrig, Dr. Stegemann 22
COVID-19 Care Pathway - Overview WHO COVID-19 Clinical management Living Guidance, January 2021 05.08.2021 Initial respiratory assessment and care - Dr. Uhrig, Dr. Stegemann 23
COVID-19 is an airborne infection Wilson NM Anaesthesia 2020;75(8):1086-1095 05.08.2021 Initial respiratory assessment and care - Dr. Uhrig, Dr. Stegemann 24
Risk Stratification Strategies and Diagnostic Modalities • Chest CT: higher sensitivity, far lower specificity (compared to RT-PCR) • Chest X-ray: lower sensitivity compared to RT-PCR and Chest CT • Lung Ultrasound: high sensitivity, point-of-care utility • ? Feasibility in every patient during a pandemic? • ? Costs of of routine diagnostic imaging (to the patient/to the health care system)? • ? Material resources on-site: how many machines? Hours of availability? • ? Availability of human resources for diagnostic imaging during a pandemic? ➠ targeted use of imaging modalities when testing resources are limited/unavailable ➠ targeted use of imaging modalities in patients with moderate/severe symptoms and concern for a false negative RT-PCR ➠ targeted use of imaging modalities in RT-PCR-positive patients with worsening symptoms Barros LM Am J Trop Med Hyg 2021;104:3-11 05.08.2021 Initial respiratory assessment and care - Dr. Uhrig, Dr. Stegemann 25
Understand how COVID-19 is transmitted Transmission by droplets Airborne transmission Large respiratory droplets that fall quickly Small infectious particles staying in the air (gravity mechanism) Droplet Precautions: Airborne precautions: • Reducing direct contact • Ventilation of rooms • Cleaning surfaces • Air filtration • Physical barriers • Reducing crowding • Physical distancing • Reducing time spent indoors • Use of masks within droplet distance • Use masks whenever indoors • Respiratory hygiene • Attention to mask quality and mask fit • Wearing high-grade protection only for • Higher-grade protection for healthcare aerosol-generating procedures staff and frontline workers 05.08.2021 Initial respiratory assessment and care - Dr. Uhrig, Dr. Stegemann 26
Evidence for airborne transmission Greenhalgh T Lancet 2021;397(10285):1603-1605 05.08.2021 Initial respiratory assessment and care - Dr. Uhrig, Dr. Stegemann 27
Respirator Activity vs. Respiratory Procedures Talking without mask Talking with mask Coughing with mask Wilson NM Anaesthesia 2021;10.1111/anae.15475 online ahead of print 05.08.2021 Initial respiratory assessment and care - Dr. Uhrig, Dr. Stegemann 28
Respirator Activity vs. Respiratory Procedures 1 3 2 4 Different time points of a cough Wilson NM Anaesthesia 2021;10.1111/anae.15475 online ahead of print (without a mask) 05.08.2021 Initial respiratory assessment and care - Dr. Uhrig, Dr. Stegemann 29
Respirator Activity vs. Respiratory Procedures HFNC NIPPV-D closed limb NIPPV-S open limb Respiratory ACTIVITY is the primary source of aerosols, NOT respiratory PROCEDURES Wilson NM Anaesthesia 2021;10.1111/anae.15475 online ahead of print 05.08.2021 Initial respiratory assessment and care - Dr. Uhrig, Dr. Stegemann 30
How to stay safe from an airborne pathogen Improve = Use N95 respirators or better + environmental ventilation + Vaccination 05.08.2021 Initial respiratory assessment and care - Dr. Uhrig, Dr. Stegemann 31
Optimizing respiratory protection Prather KA Science 2020;368(6498):1422-1424 05.08.2021 Initial respiratory assessment and care - Dr. Uhrig, Dr. Stegemann 32
Optimizing respiratory protection 05.08.2021 Initial respiratory assessment and care - Dr. Uhrig, Dr. Stegemann 33
Improve environmental ventilation 1. Outside is safest 2. Open windows 3. Avoid overcrowding 4. Set extractor fans to blow outwards 5. Unblock airvents 6. Use fans carefully 7. Caution with ductless split air conditioning systems 8. Use open vehicles for transport 9. Keep staff rooms safe 10. Optimize built-in ventilation systems of hospital buildings www.cibse.org/coronavirus-covid-19 www.ashrae.org/technical-resources/resources www.rehva.eu/activities/covid-19-guidance www.essentialcriticalcare.org 05.08.2021 Initial respiratory assessment and care - Dr. Uhrig, Dr. Stegemann 34
Planning a treatment facility for SARI Basic layout of a treatment center for Severe Acute Respiratory Infections 05.08.2021 Initial respiratory assessment and care - Dr. Uhrig, Dr. Stegemann 35
Guidance for SARI Treatment Centers 05.08.2021 Initial respiratory assessment and care - Dr. Uhrig, Dr. Stegemann 36
Testing for COVID-19: nasopharyngeal swab (video) Link to the video: https://www.facebook.com/TheNewEnglandJournalofMedicine/videos /how-to-obtain-a-nasopharyngeal-swab- specimen/686695658810993/?extid=SEO---- Marty FM N Engl J Med 2020; 382:e76 05.08.2021 Initial respiratory assessment and care - Dr. Uhrig, Dr. Stegemann 37
Laboratory diagnosis 05.08.2021 Initial respiratory assessment and care - Dr. Uhrig, Dr. Stegemann 38
Discharge criteria for confirmed COVID-19 cases TEST BASED CRITERIA: One negative result of COVID-19 RT-PCR checking for RdRp gene (CT values > 35), obtained from a sample taken after 7 days counting from the day the positive sample was collected. SYMPTOMS BASED CRITERIA: • For symptomatic patients: 10 days after symptom onset, plus at least 3 additional days without symptoms (including fever and without respiratory symptoms). • For asymptomatic patients: 10 days after positive test for Covid-19. • NB: some cases are admitted with positive COVID-19 RT-PCR results with CT values for RdRp gene more than 30 and sometimes even close to the cut off of 40. These particular situations are discussed case by case, and the control RT-PCR test might be scheduled much sooner than 7 days. Rwanda COVID-19 CLINICAL MANAGEMENT GUIDELINES, 3rd Edition Sept 2020 05.08.2021 Initial respiratory assessment and care - Dr. Uhrig, Dr. Stegemann 39
End of the first training session Questions? 05.08.2021 Initial respiratory assessment and care - Dr. Uhrig, Dr. Stegemann 40
Contact details and legal notice Contact details • EFFO@rki.de Legal Notice • Publisher: www.rki.de | Editor: www.rki.de/zbs7 • Content: www.infektiologie- pneumologie.charite.de/en/services/medical_focus/ • Illustration: www.goebel-groener.de | Photographs: www.effo.rki.de 05.08.2021 Initial respiratory assessment and care - Dr. Uhrig, Dr. Stegemann 41
You can also read